What to Expect from Johnson & Johnson’s 2Q16 Results PART 4 OF 5
Overview
Johnson & Johnson (JNJ) was experiencing difficulties in its Medical Devices business and undertook initiatives to better align the segment with the companys core business profile and medical device industry trends.
The companys restructuring initiatives involve disposing of unprofitable and low-margin businesses and making direct investments in high-margin segments. Its Cordis and Ortho-Clinical Diagnostic business divestments and its acquisition of Synt…
Read the full article at: http://marketrealist.com/2016/07/jnj-restructuring-medical-devices-business-2q16/